Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

vascuCAP

K-Number: K163071 · 2017-05-24

ApplicantElucid Bioimaging, Inc.
Decision Date2017-05-24
Product CodeLLZ
Advisory CommitteeRA
DecisionSubstantially Equivalent

Device Summary

vascuCAP is a medical device manufactured by Elucid Bioimaging, Inc.. It received FDA 510(k) clearance on 2017-05-24 under approval number K163071. The device is classified under product code LLZ. It was reviewed by the RA advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the vascuCAP?

vascuCAP is a medical device that received FDA 510(k) clearance on 2017-05-24. It is manufactured by Elucid Bioimaging, Inc.. The 510(k) number is K163071.

When was vascuCAP approved by the FDA?

vascuCAP received FDA 510(k) clearance on 2017-05-24, under approval number K163071.

What company makes vascuCAP?

vascuCAP is manufactured by Elucid Bioimaging, Inc..

What is the FDA product code for vascuCAP?

The FDA product code for vascuCAP is LLZ.

Other Devices by Elucid Bioimaging, Inc.

K183012vascuCAP K221463ElucidVivo A.3 K241524Elucid PlaqueIQ

Related Devices (Code: LLZ)

K161959ClearView cCADClearview Diagnostics, Inc. K163539Ez3D-i / E3Ewoosoft Co., Ltd. K162955Multi-Modality Tumor Tracking (MMTT) applicationPhilips Medical Systems Nederland B.V. K160852ZiaZetta Medical Technologies, LLC K162376CAAS MR 4D FlowPie Medical Imaging BV K161322CT CoPilotZepmed, LLC

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.

↑